Business Description
Botanix Pharmaceuticals Ltd
NAICS : 325414
SIC : 2836
ISIN : AU000000BOT2
Description
Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.95 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 100.33 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 23.7 | |||||
| 3-Year EPS without NRI Growth Rate | 23.7 | |||||
| 3-Year FCF Growth Rate | 3.6 | |||||
| 3-Year Book Growth Rate | -10.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 76.91 | |||||
| 9-Day RSI | 67.06 | |||||
| 14-Day RSI | 63.21 | |||||
| 6-1 Month Momentum % | 60.71 | |||||
| 12-1 Month Momentum % | 161.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.5 | |||||
| Quick Ratio | 8.14 | |||||
| Cash Ratio | 7.99 | |||||
| Days Sales Outstanding | 1049.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.5 | |||||
| Shareholder Yield % | -10.97 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 469.89 | |||||
| Operating Margin % | -10795.7 | |||||
| Net Margin % | -10778.5 | |||||
| FCF Margin % | -28839.78 | |||||
| ROE % | -35.33 | |||||
| ROA % | -32.23 | |||||
| ROIC % | -62 | |||||
| ROC (Joel Greenblatt) % | -1092.33 | |||||
| ROCE % | -35.29 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 8.1 | |||||
| Price-to-Tangible-Book | 23.5 | |||||
| EV-to-EBIT | -36.1 | |||||
| EV-to-EBITDA | -36.47 | |||||
| EV-to-Revenue | 3886.82 | |||||
| EV-to-FCF | -12.01 | |||||
| Price-to-Net-Current-Asset-Value | 23.5 | |||||
| Price-to-Net-Cash | 23.5 | |||||
| Earnings Yield (Greenblatt) % | -2.77 | |||||
| FCF Yield % | -7.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Botanix Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.093 | ||
| EPS (TTM) (A$) | -0.007 | ||
| Beta | 2.12 | ||
| Volatility % | 86.3 | ||
| 14-Day RSI | 63.21 | ||
| 14-Day ATR (A$) | 0.011492 | ||
| 20-Day SMA (A$) | 0.2205 | ||
| 12-1 Month Momentum % | 161.63 | ||
| 52-Week Range (A$) | 0.0765 - 0.24 | ||
| Shares Outstanding (Mil) | 1,575.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Botanix Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Botanix Pharmaceuticals Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Botanix Pharmaceuticals Ltd Frequently Asked Questions
What is Botanix Pharmaceuticals Ltd(ASX:BOT)'s stock price today?
The current price of ASX:BOT is A$0.24. The 52 week high of ASX:BOT is A$0.24 and 52 week low is A$0.08.
When is next earnings date of Botanix Pharmaceuticals Ltd(ASX:BOT)?
The next earnings date of Botanix Pharmaceuticals Ltd(ASX:BOT) is .
Does Botanix Pharmaceuticals Ltd(ASX:BOT) pay dividends? If so, how much?
Botanix Pharmaceuticals Ltd(ASX:BOT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers